119 related articles for article (PubMed ID: 37749318)
21. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of MSI2 predicts unfavorable outcome in adult B-acute lymphoblastic leukemia.
Aly RM; Ghazy HF
Int J Lab Hematol; 2015 Apr; 37(2):272-8. PubMed ID: 25090928
[TBL] [Abstract][Full Text] [Related]
23. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
[TBL] [Abstract][Full Text] [Related]
24. Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis.
Gu L; Zhou C; Liu H; Gao J; Li Q; Mu D; Ma Z
J Exp Clin Cancer Res; 2010 Nov; 29(1):150. PubMed ID: 21083937
[TBL] [Abstract][Full Text] [Related]
25. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-223 decreases cell proliferation, migration, invasion, and enhances cell apoptosis in childhood acute lymphoblastic leukemia via targeting Forkhead box O 1.
Li C; Zhao T; Nie L; Zou Y; Zhang Q
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32964916
[TBL] [Abstract][Full Text] [Related]
27. The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia.
Verbeke D; Demeyer S; Prieto C; de Bock CE; De Bie J; Gielen O; Jacobs K; Mentens N; Verhoeven BM; Uyttebroeck A; Boeckx N; De Keersmaecker K; Maertens J; Segers H; Cools J
Clin Cancer Res; 2020 Nov; 26(21):5747-5758. PubMed ID: 32826328
[TBL] [Abstract][Full Text] [Related]
28. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
[TBL] [Abstract][Full Text] [Related]
29. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer.
Yang H; Hu J; Chen J; Chen Z; Jiao F; Cui J; Quan M; Wang L
Med Oncol; 2020 Aug; 37(9):84. PubMed ID: 32780197
[TBL] [Abstract][Full Text] [Related]
30. Pyr3, a TRPC3 channel blocker, potentiates dexamethasone sensitivity and apoptosis in acute lymphoblastic leukemia cells by disturbing Ca(2+) signaling, mitochondrial membrane potential changes and reactive oxygen species production.
Abdoul-Azize S; Buquet C; Vannier JP; Dubus I
Eur J Pharmacol; 2016 Aug; 784():90-8. PubMed ID: 27179991
[TBL] [Abstract][Full Text] [Related]
31. Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway.
Yang C; Zhang W; Wang L; Kazobinka G; Han X; Li B; Hou T
Lab Invest; 2016 Sep; 96(9):950-8. PubMed ID: 27322953
[TBL] [Abstract][Full Text] [Related]
32. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma.
Yiming R; Takeuchi Y; Nishimura T; Li M; Wang Y; Meguro-Horike M; Kohno T; Horike SI; Nakata A; Gotoh N
Cancer Sci; 2021 Sep; 112(9):3810-3821. PubMed ID: 34145929
[TBL] [Abstract][Full Text] [Related]
33. Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
Gao C; Liu SG; Lu WT; Yue ZX; Zhao XX; Xing TY; Chen ZP; Zheng HY; Li ZG
Mol Med Rep; 2020 Oct; 22(4):2905-2915. PubMed ID: 32945392
[TBL] [Abstract][Full Text] [Related]
34. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of autophagy overcomes glucocorticoid resistance in lymphoid malignant cells.
Jiang L; Xu L; Xie J; Li S; Guan Y; Zhang Y; Hou Z; Guo T; Shu X; Wang C; Fan W; Si Y; Yang Y; Kang Z; Fang M; Liu Q
Cancer Biol Ther; 2015; 16(3):466-76. PubMed ID: 25778879
[TBL] [Abstract][Full Text] [Related]
36. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
37. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways.
Li XJ; Luo XQ; Han BW; Duan FT; Wei PP; Chen YQ
Br J Cancer; 2013 Oct; 109(8):2189-98. PubMed ID: 24030073
[TBL] [Abstract][Full Text] [Related]
39. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation.
Liu Y; Xue F; Zhang Y; Lei P; Wang Z; Zhu Z; Sun K
Anticancer Drugs; 2017 Nov; 28(10):1097-1105. PubMed ID: 28885268
[TBL] [Abstract][Full Text] [Related]
40. PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia.
Hui PY; Chen YH; Qin J; Jiang XH
Hematology; 2022 Dec; 27(1):32-42. PubMed ID: 34957927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
